Loading stock data…
Retractable Technologies, Inc. (RVP)
$0.70-0.01 (-1.52%)
Market ClosedLast close Sep 8
Retractable Technologies, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Retractable Technologies, Inc. in the Healthcare sector is trading at $0.70 with a market capitalization of $20M. The stock is currently near its 52-week low of $0.60, remaining 1.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 33) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.18M↓ | $9.44M↓ | $10.09M↓ | $10.45M↑ | $8.30M |
| Gross Profit | -$838,408↑ | -$1.53M↓ | $1.69M↑ | -$107,090↓ | -$1,911 |
| Operating Income | -$4.69M↓ | -$807,667↑ | -$3.65M↑ | -$3.66M↓ | -$3.19M |
| Net Income | -$4.23M↓ | -$2.35M↓ | $371,047↑ | -$87,471↑ | -$10.50M |
Peer Comparison
JNJUNHPFE
Fundamentals
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$19.67M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.25
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-8.97%
Volume
Today's trading volume
10,439
Recent News
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes
Retractable's second-quarter 2026 sales weaken on EasyPoint order timing, while investment gains drive earnings and tariffs remain a key sourcing challenge.
Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y
RVP's first-quarter 2026 sales decline as mix shifts and tariffs pressure pricing, prompting cost cuts and a push to expand domestic production.
RVP Stock Plunges Post Q4 Earnings Despite Revenue Growth
Retractable Technologies posts revenue growth, but widening losses, tariff pressures and weak margins underscore ongoing operational challenges and uncertain demand.
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.